Table of Content

1 Study Coverage
1.1 Gammaretroviral Vector Product Introduction
1.2 Market by Type
1.2.1 Global Gammaretroviral Vector Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Lentiviral Vectors
1.2.3 Adenoviral Vectors
1.2.4 Adeno-Associated Viral Vectors
1.2.5 Other
1.3 Market by Application
1.3.1 Global Gammaretroviral Vector Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Gene Therapy
1.3.3 Vaccinology
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Gammaretroviral Vector Sales Estimates and Forecasts 2018-2029
2.2 Global Gammaretroviral Vector Revenue by Region
2.2.1 Global Gammaretroviral Vector Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Gammaretroviral Vector Revenue by Region (2018-2024)
2.2.3 Global Gammaretroviral Vector Revenue by Region (2024-2029)
2.2.4 Global Gammaretroviral Vector Revenue Market Share by Region (2018-2029)
2.3 Global Gammaretroviral Vector Sales Estimates and Forecasts 2018-2029
2.4 Global Gammaretroviral Vector Sales by Region
2.4.1 Global Gammaretroviral Vector Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Gammaretroviral Vector Sales by Region (2018-2024)
2.4.3 Global Gammaretroviral Vector Sales by Region (2024-2029)
2.4.4 Global Gammaretroviral Vector Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Gammaretroviral Vector Sales by Manufacturers
3.1.1 Global Gammaretroviral Vector Sales by Manufacturers (2018-2024)
3.1.2 Global Gammaretroviral Vector Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gammaretroviral Vector in 2022
3.2 Global Gammaretroviral Vector Revenue by Manufacturers
3.2.1 Global Gammaretroviral Vector Revenue by Manufacturers (2018-2024)
3.2.2 Global Gammaretroviral Vector Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Gammaretroviral Vector Revenue in 2022
3.3 Global Key Players of Gammaretroviral Vector, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Gammaretroviral Vector Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Gammaretroviral Vector Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Gammaretroviral Vector, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Gammaretroviral Vector, Product Offered and Application
3.8 Global Key Manufacturers of Gammaretroviral Vector, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Gammaretroviral Vector Sales by Type
4.1.1 Global Gammaretroviral Vector Historical Sales by Type (2018-2024)
4.1.2 Global Gammaretroviral Vector Forecasted Sales by Type (2024-2029)
4.1.3 Global Gammaretroviral Vector Sales Market Share by Type (2018-2029)
4.2 Global Gammaretroviral Vector Revenue by Type
4.2.1 Global Gammaretroviral Vector Historical Revenue by Type (2018-2024)
4.2.2 Global Gammaretroviral Vector Forecasted Revenue by Type (2024-2029)
4.2.3 Global Gammaretroviral Vector Revenue Market Share by Type (2018-2029)
4.3 Global Gammaretroviral Vector Price by Type
4.3.1 Global Gammaretroviral Vector Price by Type (2018-2024)
4.3.2 Global Gammaretroviral Vector Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Gammaretroviral Vector Sales by Application
5.1.1 Global Gammaretroviral Vector Historical Sales by Application (2018-2024)
5.1.2 Global Gammaretroviral Vector Forecasted Sales by Application (2024-2029)
5.1.3 Global Gammaretroviral Vector Sales Market Share by Application (2018-2029)
5.2 Global Gammaretroviral Vector Revenue by Application
5.2.1 Global Gammaretroviral Vector Historical Revenue by Application (2018-2024)
5.2.2 Global Gammaretroviral Vector Forecasted Revenue by Application (2024-2029)
5.2.3 Global Gammaretroviral Vector Revenue Market Share by Application (2018-2029)
5.3 Global Gammaretroviral Vector Price by Application
5.3.1 Global Gammaretroviral Vector Price by Application (2018-2024)
5.3.2 Global Gammaretroviral Vector Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Gammaretroviral Vector Market Size by Type
6.1.1 US & Canada Gammaretroviral Vector Sales by Type (2018-2029)
6.1.2 US & Canada Gammaretroviral Vector Revenue by Type (2018-2029)
6.2 US & Canada Gammaretroviral Vector Market Size by Application
6.2.1 US & Canada Gammaretroviral Vector Sales by Application (2018-2029)
6.2.2 US & Canada Gammaretroviral Vector Revenue by Application (2018-2029)
6.3 US & Canada Gammaretroviral Vector Market Size by Country
6.3.1 US & Canada Gammaretroviral Vector Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Gammaretroviral Vector Sales by Country (2018-2029)
6.3.3 US & Canada Gammaretroviral Vector Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Gammaretroviral Vector Market Size by Type
7.1.1 Europe Gammaretroviral Vector Sales by Type (2018-2029)
7.1.2 Europe Gammaretroviral Vector Revenue by Type (2018-2029)
7.2 Europe Gammaretroviral Vector Market Size by Application
7.2.1 Europe Gammaretroviral Vector Sales by Application (2018-2029)
7.2.2 Europe Gammaretroviral Vector Revenue by Application (2018-2029)
7.3 Europe Gammaretroviral Vector Market Size by Country
7.3.1 Europe Gammaretroviral Vector Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Gammaretroviral Vector Sales by Country (2018-2029)
7.3.3 Europe Gammaretroviral Vector Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Gammaretroviral Vector Market Size
8.1.1 China Gammaretroviral Vector Sales (2018-2029)
8.1.2 China Gammaretroviral Vector Revenue (2018-2029)
8.2 China Gammaretroviral Vector Market Size by Application
8.2.1 China Gammaretroviral Vector Sales by Application (2018-2029)
8.2.2 China Gammaretroviral Vector Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Gammaretroviral Vector Market Size by Type
9.1.1 Asia Gammaretroviral Vector Sales by Type (2018-2029)
9.1.2 Asia Gammaretroviral Vector Revenue by Type (2018-2029)
9.2 Asia Gammaretroviral Vector Market Size by Application
9.2.1 Asia Gammaretroviral Vector Sales by Application (2018-2029)
9.2.2 Asia Gammaretroviral Vector Revenue by Application (2018-2029)
9.3 Asia Gammaretroviral Vector Sales by Region
9.3.1 Asia Gammaretroviral Vector Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Gammaretroviral Vector Revenue by Region (2018-2029)
9.3.3 Asia Gammaretroviral Vector Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Gammaretroviral Vector Market Size by Type
10.1.1 Middle East, Africa and Latin America Gammaretroviral Vector Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Gammaretroviral Vector Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Gammaretroviral Vector Market Size by Application
10.2.1 Middle East, Africa and Latin America Gammaretroviral Vector Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Gammaretroviral Vector Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Gammaretroviral Vector Sales by Country
10.3.1 Middle East, Africa and Latin America Gammaretroviral Vector Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Gammaretroviral Vector Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Gammaretroviral Vector Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novasep
11.1.1 Novasep Company Information
11.1.2 Novasep Overview
11.1.3 Novasep Gammaretroviral Vector Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Novasep Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novasep Recent Developments
11.2 MerckKGaA
11.2.1 MerckKGaA Company Information
11.2.2 MerckKGaA Overview
11.2.3 MerckKGaA Gammaretroviral Vector Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 MerckKGaA Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 MerckKGaA Recent Developments
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Information
11.3.2 Charles River Laboratories Overview
11.3.3 Charles River Laboratories Gammaretroviral Vector Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Charles River Laboratories Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Charles River Laboratories Recent Developments
11.4 UniQure N.V.
11.4.1 UniQure N.V. Company Information
11.4.2 UniQure N.V. Overview
11.4.3 UniQure N.V. Gammaretroviral Vector Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 UniQure N.V. Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 UniQure N.V. Recent Developments
11.5 Waisman Biomanufacturing
11.5.1 Waisman Biomanufacturing Company Information
11.5.2 Waisman Biomanufacturing Overview
11.5.3 Waisman Biomanufacturing Gammaretroviral Vector Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Waisman Biomanufacturing Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Waisman Biomanufacturing Recent Developments
11.6 Creative-Biogene
11.6.1 Creative-Biogene Company Information
11.6.2 Creative-Biogene Overview
11.6.3 Creative-Biogene Gammaretroviral Vector Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Creative-Biogene Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Creative-Biogene Recent Developments
11.7 Aldevron
11.7.1 Aldevron Company Information
11.7.2 Aldevron Overview
11.7.3 Aldevron Gammaretroviral Vector Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Aldevron Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Aldevron Recent Developments
11.8 Addgene
11.8.1 Addgene Company Information
11.8.2 Addgene Overview
11.8.3 Addgene Gammaretroviral Vector Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Addgene Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Addgene Recent Developments
11.9 Oxford Biomedica
11.9.1 Oxford Biomedica Company Information
11.9.2 Oxford Biomedica Overview
11.9.3 Oxford Biomedica Gammaretroviral Vector Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Oxford Biomedica Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Oxford Biomedica Recent Developments
11.10 Thermo Fisher Scientific Inc.
11.10.1 Thermo Fisher Scientific Inc. Company Information
11.10.2 Thermo Fisher Scientific Inc. Overview
11.10.3 Thermo Fisher Scientific Inc. Gammaretroviral Vector Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Thermo Fisher Scientific Inc. Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Thermo Fisher Scientific Inc. Recent Developments
11.11 Fujifilm Corporation
11.11.1 Fujifilm Corporation Company Information
11.11.2 Fujifilm Corporation Overview
11.11.3 Fujifilm Corporation Gammaretroviral Vector Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Fujifilm Corporation Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Fujifilm Corporation Recent Developments
11.12 Spark Therapeutics Inc
11.12.1 Spark Therapeutics Inc Company Information
11.12.2 Spark Therapeutics Inc Overview
11.12.3 Spark Therapeutics Inc Gammaretroviral Vector Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Spark Therapeutics Inc Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Spark Therapeutics Inc Recent Developments
11.13 ABL Inc
11.13.1 ABL Inc Company Information
11.13.2 ABL Inc Overview
11.13.3 ABL Inc Gammaretroviral Vector Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 ABL Inc Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 ABL Inc Recent Developments
11.14 Boehringer Ingelheim International GmbH
11.14.1 Boehringer Ingelheim International GmbH Company Information
11.14.2 Boehringer Ingelheim International GmbH Overview
11.14.3 Boehringer Ingelheim International GmbH Gammaretroviral Vector Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Boehringer Ingelheim International GmbH Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Boehringer Ingelheim International GmbH Recent Developments
11.15 Brammer Bio
11.15.1 Brammer Bio Company Information
11.15.2 Brammer Bio Overview
11.15.3 Brammer Bio Gammaretroviral Vector Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Brammer Bio Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Brammer Bio Recent Developments
11.16 Creative Biogene
11.16.1 Creative Biogene Company Information
11.16.2 Creative Biogene Overview
11.16.3 Creative Biogene Gammaretroviral Vector Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Creative Biogene Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Creative Biogene Recent Developments
11.17 General Electric
11.17.1 General Electric Company Information
11.17.2 General Electric Overview
11.17.3 General Electric Gammaretroviral Vector Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 General Electric Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 General Electric Recent Developments
11.18 Pfizer Inc
11.18.1 Pfizer Inc Company Information
11.18.2 Pfizer Inc Overview
11.18.3 Pfizer Inc Gammaretroviral Vector Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 Pfizer Inc Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Pfizer Inc Recent Developments
11.19 Genezen
11.19.1 Genezen Company Information
11.19.2 Genezen Overview
11.19.3 Genezen Gammaretroviral Vector Sales, Price, Revenue and Gross Margin (2018-2024)
11.19.4 Genezen Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Genezen Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Gammaretroviral Vector Industry Chain Analysis
12.2 Gammaretroviral Vector Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Gammaretroviral Vector Production Mode & Process
12.4 Gammaretroviral Vector Sales and Marketing
12.4.1 Gammaretroviral Vector Sales Channels
12.4.2 Gammaretroviral Vector Distributors
12.5 Gammaretroviral Vector Customers
13 Market Dynamics
13.1 Gammaretroviral Vector Industry Trends
13.2 Gammaretroviral Vector Market Drivers
13.3 Gammaretroviral Vector Market Challenges
13.4 Gammaretroviral Vector Market Restraints
14 Key Findings in The Global Gammaretroviral Vector Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Gammaretroviral Vector Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Lentiviral Vectors
Table 3. Major Manufacturers of Adenoviral Vectors
Table 4. Major Manufacturers of Adeno-Associated Viral Vectors
Table 5. Major Manufacturers of Other
Table 6. Global Gammaretroviral Vector Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Gammaretroviral Vector Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Gammaretroviral Vector Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Gammaretroviral Vector Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Gammaretroviral Vector Revenue Market Share by Region (2018-2024)
Table 11. Global Gammaretroviral Vector Revenue Market Share by Region (2024-2029)
Table 12. Global Gammaretroviral Vector Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Gammaretroviral Vector Sales by Region (2018-2024) & (K Units)
Table 14. Global Gammaretroviral Vector Sales by Region (2024-2029) & (K Units)
Table 15. Global Gammaretroviral Vector Sales Market Share by Region (2018-2024)
Table 16. Global Gammaretroviral Vector Sales Market Share by Region (2024-2029)
Table 17. Global Gammaretroviral Vector Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Gammaretroviral Vector Sales Share by Manufacturers (2018-2024)
Table 19. Global Gammaretroviral Vector Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Gammaretroviral Vector Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Gammaretroviral Vector, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Gammaretroviral Vector Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global Gammaretroviral Vector Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Gammaretroviral Vector by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gammaretroviral Vector as of 2022)
Table 25. Global Key Manufacturers of Gammaretroviral Vector, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Gammaretroviral Vector, Product Offered and Application
Table 27. Global Key Manufacturers of Gammaretroviral Vector, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Gammaretroviral Vector Sales by Type (2018-2024) & (K Units)
Table 30. Global Gammaretroviral Vector Sales by Type (2024-2029) & (K Units)
Table 31. Global Gammaretroviral Vector Sales Share by Type (2018-2024)
Table 32. Global Gammaretroviral Vector Sales Share by Type (2024-2029)
Table 33. Global Gammaretroviral Vector Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Gammaretroviral Vector Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Gammaretroviral Vector Revenue Share by Type (2018-2024)
Table 36. Global Gammaretroviral Vector Revenue Share by Type (2024-2029)
Table 37. Gammaretroviral Vector Price by Type (2018-2024) & (US$/Unit)
Table 38. Global Gammaretroviral Vector Price Forecast by Type (2024-2029) & (US$/Unit)
Table 39. Global Gammaretroviral Vector Sales by Application (2018-2024) & (K Units)
Table 40. Global Gammaretroviral Vector Sales by Application (2024-2029) & (K Units)
Table 41. Global Gammaretroviral Vector Sales Share by Application (2018-2024)
Table 42. Global Gammaretroviral Vector Sales Share by Application (2024-2029)
Table 43. Global Gammaretroviral Vector Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Gammaretroviral Vector Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Gammaretroviral Vector Revenue Share by Application (2018-2024)
Table 46. Global Gammaretroviral Vector Revenue Share by Application (2024-2029)
Table 47. Gammaretroviral Vector Price by Application (2018-2024) & (US$/Unit)
Table 48. Global Gammaretroviral Vector Price Forecast by Application (2024-2029) & (US$/Unit)
Table 49. US & Canada Gammaretroviral Vector Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Gammaretroviral Vector Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Gammaretroviral Vector Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Gammaretroviral Vector Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Gammaretroviral Vector Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Gammaretroviral Vector Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Gammaretroviral Vector Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Gammaretroviral Vector Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Gammaretroviral Vector Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Gammaretroviral Vector Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Gammaretroviral Vector Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Gammaretroviral Vector Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Gammaretroviral Vector Sales by Country (2024-2029) & (K Units)
Table 62. Europe Gammaretroviral Vector Sales by Type (2018-2024) & (K Units)
Table 63. Europe Gammaretroviral Vector Sales by Type (2024-2029) & (K Units)
Table 64. Europe Gammaretroviral Vector Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Gammaretroviral Vector Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Gammaretroviral Vector Sales by Application (2018-2024) & (K Units)
Table 67. Europe Gammaretroviral Vector Sales by Application (2024-2029) & (K Units)
Table 68. Europe Gammaretroviral Vector Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Gammaretroviral Vector Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Gammaretroviral Vector Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Gammaretroviral Vector Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Gammaretroviral Vector Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Gammaretroviral Vector Sales by Country (2018-2024) & (K Units)
Table 74. Europe Gammaretroviral Vector Sales by Country (2024-2029) & (K Units)
Table 75. China Gammaretroviral Vector Sales by Type (2018-2024) & (K Units)
Table 76. China Gammaretroviral Vector Sales by Type (2024-2029) & (K Units)
Table 77. China Gammaretroviral Vector Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Gammaretroviral Vector Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Gammaretroviral Vector Sales by Application (2018-2024) & (K Units)
Table 80. China Gammaretroviral Vector Sales by Application (2024-2029) & (K Units)
Table 81. China Gammaretroviral Vector Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Gammaretroviral Vector Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Gammaretroviral Vector Sales by Type (2018-2024) & (K Units)
Table 84. Asia Gammaretroviral Vector Sales by Type (2024-2029) & (K Units)
Table 85. Asia Gammaretroviral Vector Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Gammaretroviral Vector Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Gammaretroviral Vector Sales by Application (2018-2024) & (K Units)
Table 88. Asia Gammaretroviral Vector Sales by Application (2024-2029) & (K Units)
Table 89. Asia Gammaretroviral Vector Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Gammaretroviral Vector Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Gammaretroviral Vector Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Gammaretroviral Vector Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Gammaretroviral Vector Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Gammaretroviral Vector Sales by Region (2018-2024) & (K Units)
Table 95. Asia Gammaretroviral Vector Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Gammaretroviral Vector Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Gammaretroviral Vector Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Gammaretroviral Vector Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Gammaretroviral Vector Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Gammaretroviral Vector Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Gammaretroviral Vector Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Gammaretroviral Vector Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Gammaretroviral Vector Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Gammaretroviral Vector Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Gammaretroviral Vector Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Gammaretroviral Vector Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Gammaretroviral Vector Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Gammaretroviral Vector Sales by Country (2024-2029) & (K Units)
Table 109. Novasep Company Information
Table 110. Novasep Description and Major Businesses
Table 111. Novasep Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Novasep Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Novasep Recent Developments
Table 114. MerckKGaA Company Information
Table 115. MerckKGaA Description and Major Businesses
Table 116. MerckKGaA Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. MerckKGaA Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. MerckKGaA Recent Developments
Table 119. Charles River Laboratories Company Information
Table 120. Charles River Laboratories Description and Major Businesses
Table 121. Charles River Laboratories Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Charles River Laboratories Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Charles River Laboratories Recent Developments
Table 124. UniQure N.V. Company Information
Table 125. UniQure N.V. Description and Major Businesses
Table 126. UniQure N.V. Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. UniQure N.V. Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. UniQure N.V. Recent Developments
Table 129. Waisman Biomanufacturing Company Information
Table 130. Waisman Biomanufacturing Description and Major Businesses
Table 131. Waisman Biomanufacturing Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Waisman Biomanufacturing Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Waisman Biomanufacturing Recent Developments
Table 134. Creative-Biogene Company Information
Table 135. Creative-Biogene Description and Major Businesses
Table 136. Creative-Biogene Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Creative-Biogene Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Creative-Biogene Recent Developments
Table 139. Aldevron Company Information
Table 140. Aldevron Description and Major Businesses
Table 141. Aldevron Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Aldevron Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Aldevron Recent Developments
Table 144. Addgene Company Information
Table 145. Addgene Description and Major Businesses
Table 146. Addgene Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Addgene Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Addgene Recent Developments
Table 149. Oxford Biomedica Company Information
Table 150. Oxford Biomedica Description and Major Businesses
Table 151. Oxford Biomedica Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Oxford Biomedica Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Oxford Biomedica Recent Developments
Table 154. Thermo Fisher Scientific Inc. Company Information
Table 155. Thermo Fisher Scientific Inc. Description and Major Businesses
Table 156. Thermo Fisher Scientific Inc. Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Thermo Fisher Scientific Inc. Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Thermo Fisher Scientific Inc. Recent Developments
Table 159. Fujifilm Corporation Company Information
Table 160. Fujifilm Corporation Description and Major Businesses
Table 161. Fujifilm Corporation Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Fujifilm Corporation Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Fujifilm Corporation Recent Developments
Table 164. Spark Therapeutics Inc Company Information
Table 165. Spark Therapeutics Inc Description and Major Businesses
Table 166. Spark Therapeutics Inc Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. Spark Therapeutics Inc Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Spark Therapeutics Inc Recent Developments
Table 169. ABL Inc Company Information
Table 170. ABL Inc Description and Major Businesses
Table 171. ABL Inc Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. ABL Inc Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. ABL Inc Recent Developments
Table 174. Boehringer Ingelheim International GmbH Company Information
Table 175. Boehringer Ingelheim International GmbH Description and Major Businesses
Table 176. Boehringer Ingelheim International GmbH Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 177. Boehringer Ingelheim International GmbH Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Boehringer Ingelheim International GmbH Recent Developments
Table 179. Brammer Bio Company Information
Table 180. Brammer Bio Description and Major Businesses
Table 181. Brammer Bio Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 182. Brammer Bio Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
Table 183. Brammer Bio Recent Developments
Table 184. Creative Biogene Company Information
Table 185. Creative Biogene Description and Major Businesses
Table 186. Creative Biogene Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 187. Creative Biogene Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
Table 188. Creative Biogene Recent Developments
Table 189. General Electric Company Information
Table 190. General Electric Description and Major Businesses
Table 191. General Electric Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 192. General Electric Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
Table 193. General Electric Recent Developments
Table 194. Pfizer Inc Company Information
Table 195. Pfizer Inc Description and Major Businesses
Table 196. Pfizer Inc Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 197. Pfizer Inc Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
Table 198. Pfizer Inc Recent Developments
Table 199. Genezen Company Information
Table 200. Genezen Description and Major Businesses
Table 201. Genezen Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 202. Genezen Gammaretroviral Vector Product Model Numbers, Pictures, Descriptions and Specifications
Table 203. Genezen Recent Developments
Table 204. Key Raw Materials Lists
Table 205. Raw Materials Key Suppliers Lists
Table 206. Gammaretroviral Vector Distributors List
Table 207. Gammaretroviral Vector Customers List
Table 208. Gammaretroviral Vector Market Trends
Table 209. Gammaretroviral Vector Market Drivers
Table 210. Gammaretroviral Vector Market Challenges
Table 211. Gammaretroviral Vector Market Restraints
Table 212. Research Programs/Design for This Report
Table 213. Key Data Information from Secondary Sources
Table 214. Key Data Information from Primary Sources
List of Figures
Figure 1. Gammaretroviral Vector Product Picture
Figure 2. Global Gammaretroviral Vector Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Gammaretroviral Vector Market Share by Type in 2022 & 2029
Figure 4. Lentiviral Vectors Product Picture
Figure 5. Adenoviral Vectors Product Picture
Figure 6. Adeno-Associated Viral Vectors Product Picture
Figure 7. Other Product Picture
Figure 8. Global Gammaretroviral Vector Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Gammaretroviral Vector Market Share by Application in 2022 & 2029
Figure 10. Gene Therapy
Figure 11. Vaccinology
Figure 12. Other
Figure 13. Gammaretroviral Vector Report Years Considered
Figure 14. Global Gammaretroviral Vector Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Gammaretroviral Vector Revenue 2018-2029 (US$ Million)
Figure 16. Global Gammaretroviral Vector Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Gammaretroviral Vector Revenue Market Share by Region (2018-2029)
Figure 18. Global Gammaretroviral Vector Sales 2018-2029 ((K Units)
Figure 19. Global Gammaretroviral Vector Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Gammaretroviral Vector Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Gammaretroviral Vector Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Gammaretroviral Vector Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Gammaretroviral Vector Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Gammaretroviral Vector Sales YoY (2018-2029) & (K Units)
Figure 25. China Gammaretroviral Vector Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Gammaretroviral Vector Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Gammaretroviral Vector Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Gammaretroviral Vector Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Gammaretroviral Vector Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Gammaretroviral Vector Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Gammaretroviral Vector in the World: Market Share by Gammaretroviral Vector Revenue in 2022
Figure 32. Global Gammaretroviral Vector Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Gammaretroviral Vector Sales Market Share by Type (2018-2029)
Figure 34. Global Gammaretroviral Vector Revenue Market Share by Type (2018-2029)
Figure 35. Global Gammaretroviral Vector Sales Market Share by Application (2018-2029)
Figure 36. Global Gammaretroviral Vector Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Gammaretroviral Vector Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Gammaretroviral Vector Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Gammaretroviral Vector Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Gammaretroviral Vector Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Gammaretroviral Vector Revenue Share by Country (2018-2029)
Figure 42. US & Canada Gammaretroviral Vector Sales Share by Country (2018-2029)
Figure 43. U.S. Gammaretroviral Vector Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Gammaretroviral Vector Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Gammaretroviral Vector Sales Market Share by Type (2018-2029)
Figure 46. Europe Gammaretroviral Vector Revenue Market Share by Type (2018-2029)
Figure 47. Europe Gammaretroviral Vector Sales Market Share by Application (2018-2029)
Figure 48. Europe Gammaretroviral Vector Revenue Market Share by Application (2018-2029)
Figure 49. Europe Gammaretroviral Vector Revenue Share by Country (2018-2029)
Figure 50. Europe Gammaretroviral Vector Sales Share by Country (2018-2029)
Figure 51. Germany Gammaretroviral Vector Revenue (2018-2029) & (US$ Million)
Figure 52. France Gammaretroviral Vector Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Gammaretroviral Vector Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Gammaretroviral Vector Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Gammaretroviral Vector Revenue (2018-2029) & (US$ Million)
Figure 56. China Gammaretroviral Vector Sales Market Share by Type (2018-2029)
Figure 57. China Gammaretroviral Vector Revenue Market Share by Type (2018-2029)
Figure 58. China Gammaretroviral Vector Sales Market Share by Application (2018-2029)
Figure 59. China Gammaretroviral Vector Revenue Market Share by Application (2018-2029)
Figure 60. Asia Gammaretroviral Vector Sales Market Share by Type (2018-2029)
Figure 61. Asia Gammaretroviral Vector Revenue Market Share by Type (2018-2029)
Figure 62. Asia Gammaretroviral Vector Sales Market Share by Application (2018-2029)
Figure 63. Asia Gammaretroviral Vector Revenue Market Share by Application (2018-2029)
Figure 64. Asia Gammaretroviral Vector Revenue Share by Region (2018-2029)
Figure 65. Asia Gammaretroviral Vector Sales Share by Region (2018-2029)
Figure 66. Japan Gammaretroviral Vector Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Gammaretroviral Vector Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Gammaretroviral Vector Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Gammaretroviral Vector Revenue (2018-2029) & (US$ Million)
Figure 70. India Gammaretroviral Vector Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Gammaretroviral Vector Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Gammaretroviral Vector Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Gammaretroviral Vector Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Gammaretroviral Vector Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Gammaretroviral Vector Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Gammaretroviral Vector Sales Share by Country (2018-2029)
Figure 77. Brazil Gammaretroviral Vector Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Gammaretroviral Vector Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Gammaretroviral Vector Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Gammaretroviral Vector Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Gammaretroviral Vector Revenue (2018-2029) & (US$ Million)
Figure 82. Gammaretroviral Vector Value Chain
Figure 83. Gammaretroviral Vector Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed